# Prazosin and Naltrexone (PaN) Study for Veterans With Alcohol Use Disorders

> **NCT02322047** · PHASE2 · COMPLETED · sponsor: **Seattle Institute for Biomedical and Clinical Research** · enrollment: 31 (actual)

## Conditions studied

- Alcohol Use Disorder
- Posttraumatic Stress Disorder (PTSD)

## Interventions

- **DRUG:** Prazosin
- **DRUG:** Naltrexone
- **DRUG:** Placebo (Prazosin)
- **DRUG:** Placebo (Naltrexone)

## Key facts

- **NCT ID:** NCT02322047
- **Lead sponsor:** Seattle Institute for Biomedical and Clinical Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-03
- **Primary completion:** 2018-10-10
- **Final completion:** 2018-10-10
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2020-12-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02322047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02322047, "Prazosin and Naltrexone (PaN) Study for Veterans With Alcohol Use Disorders". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02322047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*